Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.
SEIS INVEST OPPORTUNITY · SOPHISTICATED & HNW INVESTORS
A large, regulated, fast-growing market with no compliance-first platform for cross-border B2B procurement. Pharmiva is building it — connecting clinics to verified suppliers across Germany, the Netherlands, Poland and the United Kingdom.
HMRC SEIS Advance Assurance applied for · Subscription documents via SeedLegals
SEIS Raise
Pre-Money
Equity
Income Tax Relief
European medical aesthetics is growing fast and professionalising under tightening regulation — yet clinics still have no compliant, cross-border way to procure injectables and devices. The backdrop is public; the platform is missing
UK practitioners across 5,589 clinics, delivering ~900,000 botulinum toxin treatments a year.
UK market in 2026, forecast to 2028 at 10.2% CAGR — Europe's most mature aesthetics market
European aesthetics market by 2028 — thousands of clinics across DE, NL and PL with no compliant digital B2B procurement platform.
Growth in male treatments since 2021; the 26–34 cohort is now the largest patient group.
European medical aesthetics is growing fast and professionalising under tightening regulation — yet clinics still have no compliant, cross-border way to procure injectables and devices. The backdrop is public; the platform is missing
Every regulatory step rewards an operator built around compliance from day one. Tightening rules turn non-compliant supply chains into licence risk — and increase the value of a platform that makes compliance frictionless. Compliance is the moat, not the cost.
Streamline your workflow with a centralized attachment management system. Easily upload, organize, and share important files securely, ensuring quick access for your team and clients.
Establish FitSource as the trusted destination connecting consumers and vendors within the performance supplement and research product ecosystem.
Dedicated to staying at the forefront of digital transformation to help businesses thrive in a constantly evolving landscape.
Develop diversified revenue streams, strengthen market positioning, and scale the platform towards strategic expansion and potential exit opportunities.
Purpose-built platform for supplements and research products.
Structured onboarding to enhance vendor credibility and trust.
Optimised search and filtering for efficient product discovery.
Analytics tools to improve vendor performance and conversions.
Commission, subscriptions, and advertising revenue streams integrated.
Clear product information supporting confident purchasing decisions.
Built for sustainable growth within evolving regulatory environments.
First-time angel investors
Experienced angels
High-conviction angels
Find clear answers to common investor questions about the FitSource opportunity, including our marketplace model, growth strategy, EIS benefits, and investment process.
FitSource is a specialised digital marketplace connecting consumers and vendors across the performance supplement and research product sectors. The platform focuses on improving product discovery, vendor distribution, and trust infrastructure within a fragmented market.
FitSource is currently in its early growth phase, with marketplace infrastructure developed and vendor onboarding underway. The raise is designed to accelerate product development, vendor acquisition, and customer growth.
The marketplace operates a scalable, asset-light model with multiple revenue streams, including transaction commissions, vendor subscriptions, featured placements, advertising opportunities, and future data-driven vendor tools.
Capital raised will be deployed across platform development, vendor acquisition, customer growth, compliance infrastructure, brand expansion, and working capital to support marketplace scaling.
Eligible investors may receive tax advantages including 30% income tax relief, capital gains tax deferral, tax-free gains on exit, potential loss relief, and inheritance tax benefits after the qualifying holding period. Investors should seek independent tax advice.
FitSource aims to become a leading niche marketplace within the performance supplement and research product ecosystem, benefiting from strong network effects and recurring purchasing behaviour. Potential exit pathways include strategic acquisition, marketplace consolidation, or future funding rounds supporting scale and liquidity.
Complete the short investor form to express interest in the FitSource EIS raise and receive the investment pack, including the deck, financials, and key terms.
Assess the opportunity, conduct your due diligence, and speak directly with the founding team to clarify valuation, allocation, and EIS eligibility before confirming your commitment.
Sign the subscription documents, transfer funds, and receive confirmation of your shareholding along with EIS documentation and ongoing investor updates.
Learn More About The Process
Have questions or need expert guidance? Connect with our team for tailored financial solutions and personalized support to meet your goals
261 Bolton Road, 2839 Davenport House, Bury, United Kingdom, BL8 2NZ
The compliance technology layer for European aesthetics.
Copyright © PHARMIVA LTD 2026 All Rights Reserved.